1. Shareholders may file claims due to misleading statements about Eylea. 2. Regeneron allegedly paid credit card fees affecting Eylea's selling price. 3. The class period for claims is November 2, 2023, to October 30, 2024. 4. Failure to disclose payment of fees potentially violated the False Claims Act. 5. Deadline to seek lead plaintiff status is March 10, 2025.
Legal challenges may create uncertainty and negatively influence investor sentiment. Past cases of similar allegations have led to stock price declines.
The lawsuit may reveal previously unknown issues that could harm investor confidence. The class action raises significant concerns about Regeneron's corporate practices.
Immediate impact due to the ongoing legal proceedings and their publicity. Historically, legal issues often affect stocks in the short term.
The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN).
Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
November 2, 2023 to October 30, 2024
The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that:
March 10, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/regeneron-pharmaceuticals-inc-loss-submission-form/?id=124349&from=4
Once you register as a shareholder who purchased shares of REGN during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is March 10, 2025. There is no cost or obligation to you to participate in this case.
The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
SOURCE The Gross Law Firm